Acura Pharmaceuticals Stock-Based Compensation 2010-2021 | ACUR
Acura Pharmaceuticals stock-based compensation from 2010 to 2021. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
Acura Pharmaceuticals Annual Stock-Based Compensation
(Millions of US $) |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$0 |
| 2016 |
$1 |
| 2015 |
$1 |
| 2014 |
$1 |
| 2013 |
$1 |
| 2012 |
$2 |
| 2011 |
$2 |
| 2010 |
$7 |
| 2009 |
$9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.001B |
$0.000B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
